Search clinical trials for: Kaletra (drug)

Total 254224 results

German Parkinson Study Group (GPS)
Assistance Publique - Hôpitaux de Paris; University Hospital Schleswig-Holstein and other collaborators

Unknown

Controlled Trial With Deep Brain Stimulation in Patients With Early Parkinson's Disease (EARLYSTIM)

Parkinson Disease

France, Germany
Fundacion SEIMC-GESIDA
Abbott

Completed

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC (KALIPO)

HIV Infections | HIV Infection

Spain
Ottawa Hospital Research Institute
Abbott

Completed

Kaletra Monotherapy in HIV/HCV Co-infected Subjects

HIV Infections

Canada
PENTA Foundation
Medical Research Council; ANRS, Emerging Infectious Diseases

Completed

KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18) (KONCERT)

Antiretroviral Therapy in HIV-1 Infected Children

Netherlands, Germany, United Kingdom, Ireland, Thailand
Lampiris, Harry W., M.D.
Abbott

Unknown

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

HIV | AIDS

United States
The HIV Netherlands Australia Thailand Research...
Chulalongkorn University; Queen Sirikit National Institute of Child Health; Srinagarind... and other collaborators

Completed

Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)

HIV-infected Children

Thailand
Therapeutic Concepts

Completed

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

HIV Infections

United States
Ines Perez

Terminated

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir (BIOKAL)

HIV Infections

Spain
University of Wisconsin, Madison

Completed

Relationship Between HIV-1 Subtype and ARV Response (RELATES)

HIV Infections

Uganda
GlaxoSmithKline

Completed

GSK706769/KALETRA Drug-drug Interaction Study

Infection, Human Immunodeficiency Virus

United States
AIDS Arms Inc.

Completed

A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort

HIV-1 | AIDS

United States
Community Research Initiative of New England
Abbott

Terminated

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

HIV Infections

United States
Oklahoma State University Center for Health Sciences
Abbott

Terminated

Kaletra and Viread in Antiretroviral Naïve Patients

HIV Infections

United States
Emory University
Abbott

Completed

Kaletra Sex/Gender Pharmacokinetics (PK) Study (LPVGenderPK)

HIV Infections

United States
Gilead Sciences

Completed

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial (ROCKET II)

HIV-1

Austria, Germany, Italy, Spain
University of Alabama at Birmingham
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Study of Subthalamic Brain Stimulation in Parkinson Disease (PD)

Parkinson Disease

United States
UPECLIN HC FM Botucatu Unesp

Unknown

Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy

HIV Infections

Brazil
University of Seville
Maastricht University; Ministerio de Ciencia, Innovación y Universidades

Recruiting

Alerta Cannabis: Evaluation of Web-based Tailored Intervention (NOTCANNABIS)

Cannabis Use | Adolescent Behavior | E-health

Spain
Albert Einstein College of Medicine
National Institute of Mental Health (NIMH)

Recruiting

A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx (CARE)

Covid19 | Parenting

United States
Globus Medical Inc

Withdrawn

Patient Outcomes Using an Expandable Spacer

Degenerative Disc Disease

United States
Abbott

Completed

Drug Use Investigation of Kaletra

Human Immunodeficiency Virus

Japan
Abbott

Completed

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

HIV-1 Infections

China
Eunice Kennedy Shriver National Institute of Child...
American Association of Colleges of Pharmacy

Completed

Lopinavir/Ritonavir (Kaletra) PK in Children

HIV Infections | HIV/AIDS Treatment

United States
AbbVie (prior sponsor, Abbott)

Completed

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Human Immunodeficiency Virus Infection
Royal Free Hampstead NHS Trust
Roche Pharma AG

Completed

Lopinavir Capsules to Kaletra or Invirase Tablets (LoCKIT)

HIV Infections

United Kingdom
Allegheny Singer Research Institute (also known...

Active, not recruiting

Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease

Epithelial Ovarian Cancer

United States
Abbott

Completed

Special Investigation of Kaletra in Pregnant Women

Human Immunodeficiency Virus

Japan
Abbott

Completed

Evaluation of Kaletra Therapy Over the Long-term

Human Immunodeficiency Virus

Germany
MedtronicNeuro

Completed

Brain Stimulation for Epilepsy Long Term Follow-up (SUDEP)

Epilepsy
Universitaire Ziekenhuizen KU Leuven

Completed

Refining the Target for Deep Brain Stimulation (DBS) in Severe, Treatment Refractory Obsessive Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Belgium
Therapeutic Concepts
Abbott; Tibotec, Inc; BluKyne

Completed

A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects (KALYINTE)

HIV Infections

United States
Merck Sharp & Dohme LLC

Terminated

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

HIV Infection
University of Alberta
Canadian Institutes of Health Research (CIHR); Gilead Sciences; Abbott

Completed

Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis (HAART)

Primary Biliary Cirrhosis

Canada
Montefiore Medical Center
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Recruiting

Engagement in CHildhood-Onset Systemic Lupus (ECHOS)

Depression | Lupus Erythematosus, Systemic

United States
University of Seville
Maastricht University; Junta de Andalucía

Completed

Alerta Alcohol. Web-based Computer-tailored Intervention for Binge-drinking Prevention in Spanish Adolescents

Alcohol Drinking | Binge Drinking | Adolescent Behavior

Spain
University of Cincinnati
Gilead Sciences; Abbott

Completed

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

HIV Infections

United States
Landon Pediatric Foundation
Gilead Sciences

Completed

Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study

Cystic Fibrosis

United States
ANRS, Emerging Infectious Diseases
Abbott

Completed

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

HIV Infections

France
Pfizer

Completed

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

HIV Infections
University of Seville
Maastricht University; Delegación del Gobierno para el Plan Nacional sobre...

Completed

An Animation- Versus Text-based Computer-tailored Game Intervention to Prevent Alcohol Consumption in Adolescents

Alcohol Drinking | Binge Drinking | Adolescent Behavior

Spain
Cancer Research UK
Aleta BioTherapeutics

Recruiting

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell

United Kingdom
University of North Carolina, Chapel Hill

Completed

The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet

Pregnancy | HIV

United States
Abbott

Completed

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Human Immunodeficiency Virus-Infection

Germany
Henry Ford Health System
Merck Sharp & Dohme LLC

Completed

Post-Exposure Prophylaxis in Health Care Workers (PEP)

Human Immunodeficiency Virus

United States
Oswaldo Cruz Foundation
Abbott

Completed

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin (A06-295)

HIV Infection | Tuberculosis

Brazil
National Institute of Allergy and Infectious Diseases...

Completed

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

HIV

United States, South Africa, Thailand, Brazil
Children's National Research Institute

Terminated

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

HIV Infections

United States
Oswaldo Cruz Foundation
Ministry of Health, Brazil

Completed

Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy

HIV Infections | Pregnancy

Brazil
Bamrasnaradura Infectious Diseases Institute

Completed

Ritonavir-boosted Lopinavir Monotherapy

HIV

Thailand
ViiV Healthcare
Pfizer

Completed

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Human Immunodeficiency Virus-1

United States, Spain, Germany

Search clinical trials for: Kaletra (drug)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations